All stock lists
Parabilis Medicines, Inc. (NASDAQ:PBLS)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
$27.07-$0.62 (-2.24%)
Market cap
$3.30B
Insider Score
Health Score
Listed since
Jun 10, 2026
Website
Insider Score
––Not scored
PBLS Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
PBLS analyst forecast
PBLS analyst consensus
No analyst ratings in the last 3 months.
PBLS 12-month price target
$40.00+49.3% upsideaverage of 1 firm
$40.00High
$40.00Low
Best analysts covering PBLS
No firm covering PBLS has a call old enough to have finished a 1Y holding period yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
PBLS analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| H.C. Wainwright | — | $40.00 | +43.6% | Price target | 2026-10-22 |
PBLS earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-05-19 | $0.00 | -$0.72 | $0 | $0 |
| 2026-08-13 | -$0.17 | -$2.32 | $16.7M | $100K |
| 2026-11-12 | -$0.36 | -$0.36 | $375K | $2.1M |
| 2027-02-11Upcoming | -$0.36 | — | $750K | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.